Table 2.
Clinical and biochemical features of control and bile duct injury (BDI) patients groups
| Group | N | Bismuth (lesion type) | Time post-lesion (days) | ALT (0-45 UI/l) |
AST (0-41 UI/l) |
DB (0.1-0.4 mg/dl) |
AP (30-115 UI/l) |
|---|---|---|---|---|---|---|---|
| Control | 1 | 0† | 0 | 16 | 18 | 0.36 | 21 |
| 2 | 0† | 0 | 5 | 6 | 0.29 | 68 | |
| 3 | 0† | 0 | 26 | 23 | 0.43 | 73 | |
| 4 | 0† | 0 | 12 | 19 | 0.12 | 49 | |
| BDI | 1 | 2 | 49 | 265 | 110 | 3.70 | 380 |
| patients | 2 | 1 | 2190 | 365 | 479 | 3.70 | 740 |
| 3 | 3 | 49 | 133 | 127 | 0.20 | 391 | |
| 4 | 3 | 489 | 54 | 58 | 5.10 | 284 | |
| 5 | 3 | 43 | 132 | 98 | 5.10 | 114 | |
| 6 | 3 | 56 | 197 | 79 | 0.90 | 378 | |
| 7 | 3 | NA | 273 | 22 | 2.80 | 899 | |
| 8 | 2 | 145 | 133 | 58 | 2.90 | 860 | |
| 9 | 3 | 65 | 164 | 168 | 2.00 | 357 | |
| 10 | 3 | 70 | 338 | 40 | .01 | 489 | |
| 11 | 3 | 42 | 285 | 85 | 6.20 | 806 | |
| 12 | 3 | 1 | 106 | 95 | 23 | 320 | |
| 13 | 3 | 1825 | 140 | NA | 0.90 | 306 | |
| 14 | 3 | 56 | 222 | 117 | NA | 296 |
† = without lesion
NA = not available